comparemela.com
Home
Live Updates
Inversago Pharma Inc.: Inversago Pharma Raises $95 million CAD in Series C Financing : comparemela.com
Inversago Pharma Inc.: Inversago Pharma Raises $95 million CAD in Series C Financing
Series C financing led by NEA Provides advancement of INV-202 Phase 2 clinical trial in Diabetic Kidney Disease in Q4 Inversago Pharma Inc. ("Inversago"), a clinical stage biotech company with a unique
Related Keywords
Germany ,
Montreal ,
Quebec ,
Canada ,
Netherlands ,
Singapore ,
Canadian ,
Inversago Pharma ,
Kostenloser Wertpapierhandel ,
Ed Mathers ,
Company Series ,
Rd Fund ,
Enterprise Associates Inc ,
Forbion Growth Opportunities Fund ,
Enterprise Associates ,
Forbion Ventures Fund Iv ,
Inversago Pharma Inc ,
Diabetic Kidney Disease ,
New Enterprise Associates ,
Growth Opportunities Fund ,
Amgen Ventures ,
Ventures Fund ,
Genesys Capital ,
Mare Bioinnovations ,
Chief Executive Officer ,
Diabetic Kidney Diseases ,
General Partner ,
Forbion Growth ,
United Nations Principles ,
Diabetic Nephropathy ,
Non Alcoholic Steatohepatitis ,
Progressive Fibrosis Interstitial Lung Disease ,
Idiopathic Pulmonary Fibrosis ,
Executive Officer ,
Inversago ,
Dharma ,
Raises ,
Billion ,
Series ,
Financing ,
comparemela.com © 2020. All Rights Reserved.